Xu C - Search Results

1

Combination therapy with HSP90 inhibitors and piperlongumine promotes ROS-mediated ER stress in colon cancer cells.

Qiu C, Shen X, Lu H, Chen Y, Xu C, Zheng P, Xia Y, Wang J, Zhang Y, Li S, Zou P, Cui R, Chen J. Qiu C, et al. Among authors: xu c. Cell Death Discov. 2023 Oct 13;9(1):375. doi: 10.1038/s41420-023-01672-y. Cell Death Discov. 2023. PMID: 37833257 Free PMC article.

2

Compensatory combination of mTOR and TrxR inhibitors to cause oxidative stress and regression of tumors.

Xia Y, Chen J, Yu Y, Wu F, Shen X, Qiu C, Zhang T, Hong L, Zheng P, Shao R, Xu C, Wu F, Chen W, Xie C, Cui R, Zou P. Xia Y, et al. Among authors: xu c. Theranostics. 2021 Feb 25;11(9):4335-4350. doi: 10.7150/thno.52077. eCollection 2021. Theranostics. 2021. PMID: 33754064 Free PMC article.

3

Glaucocalyxin B Attenuates Ovarian Cancer Cell Growth and Cisplatin Resistance In Vitro via Activating Oxidative Stress.

Zhang T, Xu C, Zheng P, Zhang X, Qiu C, Wu F, Chen J, Xiao Z, Zhu J, Zhang J, Zou P, Ni D. Zhang T, et al. Among authors: xu c. Oxid Med Cell Longev. 2022 Feb 25;2022:6324292. doi: 10.1155/2022/6324292. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 35251480 Free PMC article.

4

Combination of TrxR1 inhibitor and lenvatinib triggers ROS-dependent cell death in human lung cancer cells.

Zheng P, Xia Y, Shen X, Lu H, Chen Y, Xu C, Qiu C, Zhang Y, Zou P, Cui R, Huang X. Zheng P, et al. Among authors: xu c. Int J Biol Sci. 2024 Jan 1;20(1):249-264. doi: 10.7150/ijbs.86160. eCollection 2024. Int J Biol Sci. 2024. PMID: 38164168 Free PMC article.

5

Synergistic targeting of TrxR1 and ATM/AKT pathway in human colon cancer cells.

Shen X, Xia Y, Lu H, Zheng P, Wang J, Chen Y, Xu C, Qiu C, Zhang Y, Xiao Z, Zou P, Cui R, Ni D. Shen X, et al. Among authors: xu c. Biomed Pharmacother. 2024 May;174:116507. doi: 10.1016/j.biopha.2024.116507. Epub 2024 Apr 1. Biomed Pharmacother. 2024. PMID: 38565059 Free article.

6

Rolapitant treats lung cancer by targeting deubiquitinase OTUD3.

Du T, Gu Q, Zhang Y, Gan Y, Liang R, Yang W, Lu Y, Xu C, Wu J, Ma R, Cao H, Jiang J, Wang J, Feng J. Du T, et al. Among authors: xu c. Cell Commun Signal. 2024 Mar 27;22(1):195. doi: 10.1186/s12964-024-01519-8. Cell Commun Signal. 2024. PMID: 38539203 Free PMC article.

7

CircDCAF8 promotes the progression of hepatocellular carcinoma through miR-217/NAP1L1 Axis, and induces angiogenesis and regorafenib resistance via exosome-mediated transfer.

Gong J, Han G, Chen Z, Zhang Y, Xu B, Xu C, Gao W, Wu J. Gong J, et al. Among authors: xu c. J Transl Med. 2024 May 30;22(1):517. doi: 10.1186/s12967-024-05233-4. J Transl Med. 2024. PMID: 38816735

8

Simultaneous and ultrafast detection of pan-SARS-coronaviruses and influenza A/B viruses by a novel multiplex real-time RT-PCR assay.

Xu C, Wang Z, Yu B, Pan Z, Ni J, Feng Y, Huang S, Wu M, Zhou J, Fang L, Wu Z. Xu C, et al. Virus Res. 2024 May 28:199410. doi: 10.1016/j.virusres.2024.199410. Online ahead of print. Virus Res. 2024. PMID: 38815870

9

Nonflammable superhydrophobic passive cooling Cellulose-CaCO₃ film.

Xu CL, Yuan C, Yang Z, Xu X, Wang G, Yang Z, Cheng Z, Zhang S, Li T, Lv G, Cai J, Qi X. Xu CL, et al. J Colloid Interface Sci. 2024 May 23;671:529-542. doi: 10.1016/j.jcis.2024.05.174. Online ahead of print. J Colloid Interface Sci. 2024. PMID: 38815388

10

Oleanolic acid and its analogues: promising therapeutics for kidney disease.

Pan D, Qu Y, Shi C, Xu C, Zhang J, Du H, Chen X. Pan D, et al. Among authors: xu c. Chin Med. 2024 May 30;19(1):74. doi: 10.1186/s13020-024-00934-w. Chin Med. 2024. PMID: 38816880 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24,875 results

Search Page